We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Liberty Media Series C
FWONK
$25.8B
| $9K | ﹤0.01% |
123
+64
| +108% | +$4.33K |
|
827
Graphic Packaging
GPK
$3.53B
| $9K | ﹤0.01% |
+336
| New | +$7.9K |
|
828
Hyatt Hotels
H
$16B
| $9K | ﹤0.01% |
+81
| New | +$8.87K |
|
829
Robinhood
HOOD
$85B
| $9K | ﹤0.01% |
978
+703
| +256% | +$6.71K |
|
830
MongoDB
MDB
$33.5B
| $9K | ﹤0.01% |
39
+25
| +179% | +$5.25K |
|
831
Sunrun
RUN
$2.38B
| $9K | ﹤0.01% |
+434
| New | +$10.1K |
|
832
SentinelOne
S
$7.62B
| $9K | ﹤0.01% |
558
+490
| +721% | +$7.4K |
|
|
SEE
833
DELISTED
Sealed Air
SEE
| $9K | ﹤0.01% |
+187
| New | +$9.29K |
|
|
EVA
834
DELISTED
Enviva Inc.
EVA
| $9K | ﹤0.01% |
+300
| New | +$12.2K |
|
|
SPLK
835
DELISTED
Splunk Inc
SPLK
| $9K | ﹤0.01% |
89
-3,464
| -97% | -$332K |
|
836
Credit Acceptance
CACC
$6.03B
| $8K | ﹤0.01% |
+19
| New | +$8.35K |
|
|
CFLT
837
DELISTED
Confluent
CFLT
| $8K | ﹤0.01% |
+343
| New | +$7.95K |
|
838
East-West Bancorp
EWBC
$18.1B
| $8K | ﹤0.01% |
+148
| New | +$10.2K |
|
839
F&G Annuities & Life
FG
$3.55B
| $8K | ﹤0.01% |
+462
| New | +$9.25K |
|
840
GoDaddy
GDDY
$11.6B
| $8K | ﹤0.01% |
101
-4,629
| -98% | -$357K |
|
841
Loews
L
$23.3B
| $8K | ﹤0.01% |
+130
| New | +$7.7K |
|
842
Liberty Broadband Class A
LBRDA
$5.17B
| $8K | ﹤0.01% |
101
+69
| +216% | +$5.95K |
|
843
New Fortress Energy
NFE
$97.8M
| $8K | ﹤0.01% |
260
-23
| -8% | -$811 |
|
|
OLPX
844
DELISTED
Olaplex Holdings
OLPX
| $8K | ﹤0.01% |
1,798
+1,554
| +637% | +$8.28K |
|
845
Toast
TOST
$20.6B
| $8K | ﹤0.01% |
428
+275
| +180% | +$5.42K |
|
846
Westlake Corp
WLK
$10.1B
| $8K | ﹤0.01% |
71
+32
| +82% | +$3.69K |
|
847
Zscaler
ZS
$28.6B
| $8K | ﹤0.01% |
67
+50
| +294% | +$6K |
|
|
BZUN
848
Baozun
BZUN
$170M
| $7K | ﹤0.01% |
+1,182
| New | +$7.79K |
|
849
Definitive Healthcare
DH
$73.7M
| $7K | ﹤0.01% |
650
+493
| +314% | +$5.8K |
|
850
nCino
NCNO
$2.08B
| $7K | ﹤0.01% |
+292
| New | +$7.7K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.